Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]2-(p-substituted phenyl)benzoxazoles

被引:48
作者
Temiz-Aripaci, Ö
Özdemir, A
Yalçin, I
Yildiz, I
Aki-Sener, E [1 ]
Altanlar, N
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-06100 Ankara, Turkey
[2] Ankara Univ, Fac Pharm, Dept Microbiol, Ankara, Turkey
关键词
benzoxazoles; antibacterial activity; antifungal activity; morpholine aceteamide; piperazine acetamide;
D O I
10.1002/ardp.200400923
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, a series of twelve novel 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazine-1-yl)acetamido]-2-(p-substituted phenyl]benzoxazole derivatives have been synthesized and their structures were confirmed by IR, H-1 NMR, and mass spectral data. These compounds were prepared by reacting 5-(2-chloroacetamido)-2-(4-p-substituted-phenyl)benzoxazoles, which were obtained by using 5-amino-2-[p-substituted-phenyl]benzoxazoles with chloroacetyl chloride, in the presence of morpholine or I-substituted piperazines. All synthesized compounds 3-14 were tested by using the method of twofold serial dilution technique for in vitro activities against certain strains of Gram-positive, Gram-negative bacteria as well as the yeasts Candida albicans, Candida krusei, and Candida glabrata in comparison with standard drugs. Microbiological results showed that the newly synthesized compounds possessed a broad spectrum of activity, showing MIC values of 3.12-50 mu g/mL against the Candida species.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 36 条
[1]  
[Anonymous], TETRAHEDRON
[2]  
ARPAI OT, 2002, ARCH PHARM PHARM MED, V335, P283
[3]  
CHARLES ES, 1979, EUR J MED CHEM, V14, P435
[4]   PLASMA VIREMIA AS A SENSITIVE INDICATOR OF THE ANTIRETROVIRAL ACTIVITY OF L-697,661 [J].
DAVEY, RT ;
DEWAR, RL ;
REED, GF ;
VASUDEVACHARI, MB ;
POLIS, MA ;
KOVACS, JA ;
FALLOON, J ;
WALKER, RE ;
MASUR, H ;
HANEIWICH, SE ;
ONEILL, DG ;
DECKER, MR ;
METCALF, JA ;
DELORIA, MA ;
LASKIN, OL ;
SALZMAN, N ;
LANE, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5608-5612
[5]   The total synthesis of UK-1 [J].
DeLuca, MR ;
Kerwin, SM .
TETRAHEDRON LETTERS, 1997, 38 (02) :199-202
[6]   Syntheses of 2-(bromodifluoromethyl)benzoxazole and 5-(bromodifluoromethyl)-1,2,4-oxadiazoles [J].
Dolbier, WR ;
Burkholder, CR ;
Médebielle, M .
JOURNAL OF FLUORINE CHEMISTRY, 1999, 95 (1-2) :127-130
[7]  
ElShaaer HM, 1997, PHARMAZIE, V52, P585
[8]  
Ersan S, 1997, ARZNEIMITTELFORSCH, V47, P963
[9]   Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium 2. Isolation and structural elucidation [J].
Fudou, R ;
Iizuka, T ;
Sato, S ;
Ando, T ;
Shimba, N ;
Yamanaka, S .
JOURNAL OF ANTIBIOTICS, 2001, 54 (02) :153-156
[10]   A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS [J].
GOLDMAN, ME ;
OBRIEN, JA ;
RUFFING, TL ;
SCHLEIF, WA ;
SARDANA, VV ;
BYRNES, VW ;
CONDRA, JH ;
HOFFMAN, JM ;
EMINI, EA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :947-949